Hoffmann-La Roche Limited et al. v Pfizer Canada Inc.
2018
T-401-18
Resolved
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)
Counsel to:
Pfizer Canada Inc.
The decision is reported
here.
Meet the team
![Meghan A. Dureen, Ph.D.](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bae05e71cd3af89ae952_meghan-bw-min.jpeg)
Meghan A. Dureen, Ph.D.
Counsel
![Nathaniel Dillonsmith](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bab4006d422e2353fe2b_nathaniel-bw-min.jpeg)
Nathaniel Dillonsmith
Associate